| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |